Literature DB >> 31991210

Characterization of three novel β-galactosidases from Akkermansia muciniphila involved in mucin degradation.

Konrad Kosciow1, Uwe Deppenmeier2.   

Abstract

The gut microbe Akkermansia (A.) muciniphila becomes increasingly important as its prevalence is inversely correlated with different human metabolic disorders and diseases. This organism is a highly potent degrader of intestinal mucins and the hydrolyzed glycan compounds can then serve as carbon sources for the organism itself or other members of the gut microbiota via cross-feeding. Despite its importance for the hosts' health and microbiota composition, exact mucin degrading mechanisms are still mostly unclear. In this study, we identified and characterized three extracellular β-galactosidases (Amuc_0771, Amuc_0824, and Amuc_1666) from A. muciniphila ATCC BAA-835. The substrate spectrum of all three enzymes was analyzed and the results indicated a preference for different galactosidic linkages for each hydrolase. All preferred target structures are prevalent within mucins of the colonic habitat of A. muciniphila. To check a potential function of the enzymes for the degradation of mucosal glycan structures, porcine stomach mucin was applied as a model substrate. In summary, we could confirm the involvement of all three β-galactosidases from A. muciniphila in the complex mucin degradation machinery of this important gut microbe. These findings could contribute to the understanding of the molecular interactions between A. muciniphila and its host on a molecular level.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Enzyme characterization; Human gut; Intestinal tract; Microbiota; Mucin; Mucin-degrading bacteria

Mesh:

Substances:

Year:  2020        PMID: 31991210     DOI: 10.1016/j.ijbiomac.2020.01.246

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  9 in total

Review 1.  Proteomics and Metaproteomics Add Functional, Taxonomic and Biomass Dimensions to Modeling the Ecosystem at the Mucosal-luminal Interface.

Authors:  Leyuan Li; Daniel Figeys
Journal:  Mol Cell Proteomics       Date:  2020-06-24       Impact factor: 5.911

2.  The Bacterium Akkermansia muciniphila: A Sentinel for Gut Permeability and Its Relevance to HIV-Related Inflammation.

Authors:  Jing Ouyang; John Lin; Stéphane Isnard; Brandon Fombuena; Xiaorong Peng; André Marette; Bertrand Routy; Meriem Messaoudene; Yaokai Chen; Jean-Pierre Routy
Journal:  Front Immunol       Date:  2020-04-09       Impact factor: 7.561

3.  Human mesenchymal stem cells treatment improved hepatic lesions and reversed gut microbiome disorder in non-alcoholic steatohepatitis.

Authors:  Zhiyu Yang; Qiaoyun Xia; Di Lu; Han Yue; Jianmin Zhang; Yalong Li; Bingyong Zhang; Xiuling Li; Mingbo Cao
Journal:  Aging (Albany NY)       Date:  2020-11-08       Impact factor: 5.682

4.  Akkermansia muciniphila: is it the Holy Grail for ameliorating metabolic diseases?

Authors:  Juan Yan; Lili Sheng; Houkai Li
Journal:  Gut Microbes       Date:  2021 Jan-Dec

5.  In vitro co-metabolism of epigallocatechin-3-gallate (EGCG) by the mucin-degrading bacterium Akkermansia muciniphila.

Authors:  Yun Xia; Xuxiang Zhang; Mingxin Jiang; Hongbo Zhang; Yinfeng Wang; Yuyu Zhang; Robert Seviour; Yunhong Kong
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

Review 6.  How microbial glycosyl hydrolase activity in the gut mucosa initiates microbial cross-feeding.

Authors:  Maryse D Berkhout; Caroline M Plugge; Clara Belzer
Journal:  Glycobiology       Date:  2022-03-30       Impact factor: 4.313

Review 7.  Novel Candidate Microorganisms for Fermentation Technology: From Potential Benefits to Safety Issues.

Authors:  Duygu Ağagündüz; Birsen Yılmaz; Tevfik Koçak; Hilal Betül Altıntaş Başar; João Miguel Rocha; Fatih Özoğul
Journal:  Foods       Date:  2022-10-04

Review 8.  Mucosal glycan degradation of the host by the gut microbiota.

Authors:  Andrew Bell; Nathalie Juge
Journal:  Glycobiology       Date:  2021-06-29       Impact factor: 4.313

9.  Akkermansia muciniphila uses human milk oligosaccharides to thrive in the early life conditions in vitro.

Authors:  Ioannis Kostopoulos; Janneke Elzinga; Noora Ottman; Jay T Klievink; Bernadet Blijenberg; Steven Aalvink; Sjef Boeren; Marko Mank; Jan Knol; Willem M de Vos; Clara Belzer
Journal:  Sci Rep       Date:  2020-08-31       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.